Filing Details
- Accession Number:
- 0001683168-24-001322
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 16:05:35
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-03-05 16:05:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1402328 | Sunshine Biopharma Inc | SBFM | Pharmaceutical Preparations (2834) | 205566275 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1474684 | N. Steve Slilaty | 1177 Avenue Of The Americas, 5Th Floor New York NY 10036 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock | Acquisiton | 2024-03-04 | 100,000 | $0.10 | 130,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
